Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_assertion type Assertion NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_head.
- NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_assertion description "[Phase II randomized trial comparing high-dose IFN-?2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_provenance.
- NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_assertion evidence source_evidence_literature NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_provenance.
- NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_assertion SIO_000772 23833309 NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_provenance.
- NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_assertion wasDerivedFrom befree-20150227 NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_provenance.
- NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_assertion wasGeneratedBy ECO_0000203 NP476607.RAtbOz7xcCiba6RBFU-B7wcNINqQn1Ln3uGCYIgJKKhSE130_provenance.